Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 26.80
+0.18 (0.68%)
May 9, 2025, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 8.99 billion as of May 9, 2025. Its market cap has increased by 82.92% in one year.
Market Cap
8.99B
Enterprise Value
8.87B
Revenue
783.21M
Ranking
n/a
PE Ratio
184.09
Stock Price
26.80
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 8.99B, an increase of 5,816.27%. That is a compound annual growth rate of 72.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.17B |
| Pro Medicus | 25.61B |
| Cochlear | 17.37B |
| Sonic Healthcare | 12.74B |
| Ramsay Health Care | 8.21B |
| Ansell | 4.60B |
| Regis Healthcare | 2.24B |
| Mesoblast | 2.23B |